Application of 2-octyl-3-isothiazolinone in prevention and treatment of fungal diseases of tobacco and identification method of 2-octyl-3-isothiazolinone
The 2-octyl-3-isothiazolinone identified from the co-culture metabolites of Bacillus subtilis and Trichoderma accretion, the problem of resistance to chemical pesticides by tobacco black tibia and red star disease was solved, and high efficiency was achieved green prevention and control effect.
Patent Information
- Application Number
- CN202411111494.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-12-03
AI Technical Summary
The prevention and treatment of tobacco black tibia and red star disease mainly relies on chemical pesticides. The agent varieties are single and have outstanding resistance, and there is a lack of effective alternative agents.
A novel antibacterial substance 2-octyl-3-isothiazolinone was identified from co-culture metabolites of Bacillus subtilis and T. anaphylaxis, which was used as a green control agent to prevent and treat tobacco black tibia and red star disease.
2-octyl-3-isothiazolinone has significant inhibitory activity on tobacco black tibia and red star disease. Through root spraying or foliar spraying, it achieves a disease prevention effect of 92.38% to 100%, which is better than traditional agents.
Smart Images

Figure CN119054702A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to application of 2-octyl-3-isothiazolinone in preventing and controlling tobacco fungal diseases and an identification method thereof, belonging to the technical field of fungal disease prevention and control. Background Art
[0002] Tobacco is an important cash crop in my country. However, tobacco is a leaf-growing cash crop and is easily damaged by various pests and diseases during its growth. Among them, tobacco black shank and brown spot disease are very serious. At present, the prevention and control of the above two diseases in production mainly rely on chemical pesticides. The main pesticides such as metalaxyl mancozeb, oxazolidinone, cymoxanil, and sclerotin have been used for a long time. Due to the relatively single variety of pesticides, the problem of pesticide resistance is becoming increasingly prominent, and new alternatives need to be developed urgently. Summary of the invention
[0003] The invention provides a novel antibacterial substance 2-octyl-3-isothiazolinone identified from the metabolites of co-culture of Bacillus subtilis and Trichoderma acanthosporium. The compound has strong inhibitory activity against tobacco black shank pathogen and red star pathogen, can be used for the green prevention and control of tobacco black shank pathogen and red star pathogen, and can overcome the shortcomings of the prior art.
[0004] The technical solution of the present invention:
[0005] Application of 2-octyl-3-isothiazolinone as an antibacterial substance.
[0006] Application of 2-octyl-3-isothiazolinone as a control agent for tobacco black shank disease.
[0007] Application of 2-octyl-3-isothiazolinone for the prevention and treatment of tobacco brown spot disease.
[0008] The molecular formula of the 2-octyl-3-isothiazolinone is C 11 H 19 NOS, the structural formula is shown in I:
[0009]
[0010] I
[0011] The aforementioned 2-octyl-3-isothiazolinone is identified from the metabolites of co-culture of Bacillus subtilis and Trichoderma aculeatus.
[0012] The aforementioned 2-octyl-3-isothiazolinone is identified from the metabolites of co-culture of Bacillus subtilis and Trichoderma aculeatus by the following steps:
[0013] (1) Trichoderma aspergillus HG1 was cultured in PDA medium at 28°C for 5 days, the spores were washed with sterile water, 20 μL of the spore suspension was dropped into a cell counting plate and the number of spores was counted using an automatic cell counter, and the concentration of the spore suspension was adjusted to 1×105 CFU / mL with sterile water to obtain a Trichoderma aspergillus HG1 spore suspension;
[0014] Bacillus subtilis Tpb55 was cultured in NA medium for 24 h, inoculated in LB medium, and cultured at 28°C and 180 rpm for 24 h. 200 μL of bacterial solution was placed in a microplate and the OD600 value was read by a microplate reader. The bacterial solution was diluted to a concentration of 1×106 CFU / mL with sterile water to obtain a Tpb55 bacterial suspension.
[0015] (2) 5 mL of Trichoderma aspergillus HG1 spore suspension was inoculated into 250 mL of LB medium alone, and fermented at 28°C and 180 rpm for 7 days to obtain a single culture fermentation liquid H; 500 μL of Bacillus subtilis Tpb55 bacterial suspension was inoculated into 250 mL of LB medium alone, and fermented at 28°C and 180 rpm for 6 days to obtain a single culture fermentation liquid T; 5 mL of Trichoderma aspergillus HG1 and 500 μL of Bacillus subtilis Tpb55 were sequentially inoculated into LB broth with an inoculation time interval of 24 hours, and co-cultured at 28°C and 180 rpm for 7 days to obtain a co-culture fermentation liquid HT;
[0016] (3) 50 mL of each H, T and HT fermentation broth was centrifuged at 6000 rpm for 5 min, washed with PBS buffer, and centrifuged three times to remove the culture medium to obtain mycelial extracts, which were quickly frozen in liquid nitrogen and stored at -80°C; 100 mg of each sample was placed in a 1.5 mL microcentrifuge tube, 500 μL of 80% methanol aqueous solution was added, vortexed and ice-bathed for 5 min, centrifuged at 4°C and 15000 rpm for 20 min, and the supernatant was collected for LC-MS analysis; LC-MS / MS used the following elution system in positive and negative ion modes: positive ion mode, mobile phase 0.1% formic acid and mobile phase methanol; negative ion mode, mobile phase 5 mM ammonium acetate, pH 9.0 and mobile phase methanol; column temperature was set to 40°C, flow rate 0.2 mL / min; elution gradient was set as follows: 0 min, 12% B; 1.5 min, 2% B; 12 min, 100% B; 14 min, 100% B; 14.1min, 2%B; 17min, 2%B;
[0017] (4) The raw data were screened for parameters such as retention time and charge-to-mass ratio using Compound Discoverer 3.1, and then each metabolite was pre-aligned, peak extracted, and peak area quantified. The obtained information was then compared with three databases: mzCloud, mzVault, and Masslist, and the metabolite identification and relative quantification results were finally obtained. Statistical analysis was performed using statistical software R version R-3.4.3, Python 2.7.6version, and CentOS release 6.6. Partial least squares discriminant analysis (PLS-DA) was performed using metabolomics data processing software metaX. The statistical significance p-value and differential fold change of metabolites between groups were calculated based on the univariate analysis T test. The screening criteria for differential metabolites were VIP>1.0, FC>1.5 or FC<0.667, and p-value<0.05.
[0018] Metabolomic analysis showed that co-culture of Trichoderma aspergillus HG1 and Bacillus subtilis Tpb55 could promote the production of secondary metabolites with antibacterial activity, including 2-octyl-3-isothiazolinone.
[0019] Compared with the prior art, the invention uses a novel antibacterial substance 2-octyl-3-isothiazolinone identified from the metabolites of co-culture of bacillus subtilis and trichoderma aspergillus, and uses the 2-octyl-3-isothiazolinone in a tobacco pot test. The test shows that the 2-octyl-3-isothiazolinone has excellent disease prevention effects on tobacco black shank and brown spot disease, wherein the effects of root irrigation treatment with 100 μg / mL and 200 μg / mL 2-octyl-3-isothiazolinone dilutions on preventing and controlling tobacco black shank disease are 92.38% and 100% respectively; and the effects of spraying 100 μg / mL and 200 μg / mL 2-octyl-3-isothiazolinone on tobacco leaves on preventing and controlling brown spot disease are 80.80% and 84.33% respectively. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 This is the clustering heat map of HT-T differential metabolites;
[0021] Figure 2 This is the clustering heat map of HT-H differential metabolites;
[0022] Figure 3 This is a test diagram showing that different metabolites show different antibacterial abilities against tobacco phytophthora, in which (A) malic acid; (B) azelaic acid; (C) undecenoic acid; (D) paromomycin; (E) carvone; (F) linoleic acid; (G) octenone; (H) palmitoleic acid;
[0023] Figure 4The results show the antibacterial effects of 2-octyl-3-isothiazolinone and paromomycin on common oomycetes Pythium coloratum, Pythiumultimum, Pythium aphanidermatum, Phytophthora sojae and Phytophthora capsici. DETAILED DESCRIPTION
[0024] Example 1: Identification of 2-octyl-3-isothiazolinone
[0025] (1) Construction of co-culture system
[0026] The Trichoderma aspergillus HG1 was cultured in PDA medium at 28°C for 5 days, the spores were washed with sterile water, 20 μL of the spore suspension was dropped into a cell counting plate and the number of spores was counted using an automatic cell counter, the concentration of the spore suspension was adjusted to 1×105 CFU / mL with sterile water, and the Trichoderma aspergillus HG1 spore suspension was obtained.
[0027] Bacillus subtilis Tpb55 was cultured in NA medium for 24 h, inoculated into LB medium, and cultured at 28°C and 180 rpm for 24 h. 200 μL of the bacterial solution was placed in a microplate and the OD600 value was read by a microplate reader. The bacterial solution was diluted to 1×106 CFU / mL with sterile water to obtain a Tpb55 bacterial suspension.
[0028] 5 mL of Trichoderma aspergillus HG1 spore suspension was inoculated into 250 mL of LB medium alone, and fermented at 28°C and 180 rpm for 7 days to obtain a single culture fermentation liquid H. 500 μL of Bacillus subtilis Tpb55 bacterial suspension was inoculated into 250 mL of LB medium alone, and fermented at 28°C and 180 rpm for 6 days to obtain a single culture fermentation liquid T. 5 mL of Trichoderma aspergillus HG1 and 500 μL of Bacillus subtilis Tpb55 were sequentially inoculated into LB broth with an inoculation time interval of 24 h, and co-cultured at 28°C and 180 rpm for 7 days to obtain a co-culture fermentation liquid HT.
[0029] 50 mL of H, T and HT fermentation broth were centrifuged (6000 rpm) for 5 min, washed with PBS buffer, centrifuged 3 times to remove the culture medium, and mycelial extracts were obtained. After quick freezing in liquid nitrogen, they were stored at -80°C. 100 mg of each sample was taken in a 1.5 mL microcentrifuge tube, 500 μL of 80% methanol aqueous solution was added, vortexed and ice-bathed for 5 min, and centrifuged at 4°C and 15000 rpm for 20 min. The supernatant was collected for LC-MS analysis. LC-MS / MS used different elution systems in positive and negative ion modes (positive ion mode, mobile phase A (0.1% formic acid) and mobile phase B (methanol); negative ion mode, mobile phase A (5 mM ammonium acetate, pH 9.0) and mobile phase B (methanol)). The column temperature was set to 40°C and the flow rate was 0.2 mL / min. The elution gradient was set as follows: 0 min, 12% B; 1.5 min, 2% B; 12 min, 100% B; 14 min, 100% B; 14.1 min, 2% B; 17 min, 2% B.
[0030] The raw data were screened by Compound Discoverer 3.1 (CD 3.1, ThermoFisher) for parameters such as retention time and charge-to-mass ratio, and then each metabolite was pre-aligned, peak extracted, and peak area quantified. The information obtained was then compared with three databases, mzCloud (https: / / www.mzcloud.org / ), mzVault, and Masslist, and the results of metabolite identification and relative quantification were finally obtained. Statistical analysis was performed using statistical software R (R version R-3.4.3), Python (Python 2.7.6version), and CentOS (CentOS release6.6). Partial least squares discriminant analysis (PLS-DA) was performed by metabolomics data processing software metaX. The statistical significance (p-value) and difference fold (fold change) of metabolites between groups were calculated based on univariate analysis (T test). The screening criteria for differential metabolites were VIP>1.0, FC>1.5 or FC<0.667 and p-value<0.05. Based on the relative or absolute quantitative results of the metabolites, the fold change of the expression level of a certain metabolite between the two groups was calculated, referred to as the FC value.
[0031] Metabolomics analysis showed that co-culture of Trichoderma aspergillus HG1 with Bacillus subtilis Tpb55 promoted the production of secondary metabolites with antimicrobial activity. Compared with T, the antimicrobial secondary metabolites with increased production in HT included L-pyroglutamic acid, caffeine, hordenine, galangin, 2-octyl-3-isothiazolinone, 4-isopropylbenzaldehyde, mandelic acid, 10-undecenoic acid, azelaic acid, and (10E,15Z)-9,12,13-trihydroxyoctadecane-10,15-dienoic acid ( Figure 1 ). Among them, the fatty acids - (10E, 15Z)-9,12,13-trihydroxyoctadecane-10,15-dienoic acid, azelaic acid and 10-undecenoic acid - were the most significantly changed compounds, increasing by 3175.5-fold, 60.8-fold and 52.1-fold, respectively. Compared with H, the antimicrobial metabolites upregulated in HT were 10-undecenoic acid (4.4-fold), carvone (3.1-fold) and paromomycin (1.7-fold) ( Figure 2 ). Compared with H monoculture, other substances beneficial to microorganisms were significantly upregulated in HT, such as traumatic acid, jasmonic acid, shikimic acid, and 4-ketoretinol. Cluster analysis of the main antimicrobial and beneficial metabolites detected in HT co-culture revealed that these metabolites were significantly upregulated compared with monoculture.
[0032] Example 2: Determination of antibacterial activity of 2-octyl-3-isothiazolinone
[0033] The antibacterial activity of differential metabolites of co-culture of Trichoderma aculeatus HG1 and Bacillus subtilis Tpb55 compared with single culture of the two strains was determined by hyphae growth rate method. Some differential metabolites with known characteristics were not tested. The differential metabolites selected were malic acid, azelaic acid, undecylenic acid, paromomycin, carvone, linoleic acid, 2-octyl-3-isothiazolinone, and palmitoleic acid. Tobacco black leg pathogen and tobacco red star pathogen activated for 3-4 days in a 28°C incubator were taken with a 5mm puncher and inoculated in the center of OA and PDA plates with a differential metabolite concentration of 100μg / mL (the differential metabolites were first dissolved in DMSO and then dissolved in the culture medium plate), and the culture medium plate containing 0.5% DMSO was used as a control, and cultured at 28°C for 96h. The hyphae growth diameter was determined by the cross method, and the inhibition rate was calculated. The EC50 of 2-octyl-3-isothiazolinone (0.025, 0.05, 0.1, 0.5, 1 μg / mL) against tobacco black shank pathogen and red star pathogen was further determined.
[0034] The results are shown in Table 1 and Figure 3 As shown in the figure, the tested differentially metabolized compounds showed different antibacterial abilities against Phytophthora nicotianae. Among them, 2-octyl-3-isothiazolinone and paromomycin had better antibacterial effects.
[0035] Table 1 Antibacterial activity of secondary metabolites against tobacco black shank pathogen
[0036]
[0037]
[0038] Note: Different lowercase letters after the same column of data in the table indicate that the differences among treatments are statistically significant (p≤0.05)
[0039] We tested the antibacterial effects of 2-octyl-3-isothiazolinone and paromomycin at a concentration of 100 μg / mL on the common oomycetes Pythium coloratum, Pythium ultimum, Pythium aphanidermatum, Phytophthora sojae and Phytophthora capsici. The test structure was that the inhibition rate was 100% ( Figure 4 , CK in the figure is DMSO).
[0040] The EC50 of 2-octyl-3-isothiazolinone against tobacco black leg pathogen was 0.43 μg / mL, and that against tobacco brown spot pathogen was 1.35 μg / mL (Y=4.8120+1.4558X, r=0.9877).
[0041] Example 3: Potted plant test of 2-octyl-3-isothiazolinone for controlling tobacco black shank
[0042] Preparation of millet with black leg pathogen: Boil millet with water until two-thirds of the husk is broken, filter through gauze and dry in the air (containing 15% water), and place in a conical bottle for sterilization (121°C, 20 minutes). After activating tobacco phytophthora on oatmeal agar (OA) medium for 7 days, use a hole puncher to take the bacterial cake and inoculate it into the sterilized millet medium (5 mm in diameter, 3 bacterial cakes per bottle), and culture at 26°C for 14 days.
[0043] The soil was mixed with Phytophthora fungus (1kg soil: 4g fungus) as the diseased soil for the pot test. The test soil came from the Jimo Experimental Base of the Tobacco Research Institute of the Chinese Academy of Agricultural Sciences (field natural soil: sterilized matrix soil = 7:3). Five-leaf tobacco seedlings with consistent growth were selected and transplanted into the diseased soil, and the roots were irrigated with 100μg / mL and 200μg / mL of 2-octyl-3-isothiazolinone dilutions, 10mL per tobacco seedling. The root irrigation treatment of 0.5% DMSO (CK) was used as the control. There was one tobacco plant in each pot, 15 plants in each treatment, and repeated 3 times. On the 7th day after transplanting, the incidence of tobacco black shank disease in different treatments was investigated by plant, and the disease index and disease prevention effect were statistically calculated. The results are shown in Table 2. 2-Octyl-3-isothiazolinone has an excellent disease prevention effect on tobacco black shank. The effects of root irrigation treatment with 100 μg / mL and 200 μg / mL 2-octyl-3-isothiazolinone dilutions on the prevention and control of tobacco black shank were 92.38% and 100%, respectively, which has good application potential.
[0044] Table 2 Potted experiment on the control of tobacco black shank by 2-octyl-3-isothiazolinone
[0045] deal with Disease index Relative efficacy (%) CK (0.5% DMSO) 75.30a - 100μg / mL 2-octyl-3-isothiazolinone 5.74b 92.38b 200 μg / mL 2-octyl-3-isothiazolinone 0.00c 100%a
[0046] Example 4: Field trial of 2-octyl-3-isothiazolinone in controlling tobacco brown spot disease
[0047] The field experiment on the prevention and control of tobacco brown spot disease was carried out at the Jimo Experimental Base of the Tobacco Research Institute of the Chinese Academy of Agricultural Sciences in 2023. There are 4 treatments in the experiment: (1) CK (control); (2) 100μg / mL 2-octyl-3-isothiazolinone; (3) 200μg / mL 2-octyl-3-isothiazolinone; (4) 400 times dilution of 40% Sclerotium. Each plot is 60 square meters and has 100 tobacco plants. The test tobacco variety is Xiaohuangjin 1025. When the tobacco brown spot disease first occurs in the field (July 17), the leaves are evenly sprayed. After two consecutive applications, each with an interval of 7-8 days, the field disease situation is investigated on the 7th day after the last application (August 10), and the disease index and disease prevention effect are calculated.
[0048] The test results are shown in Table 3. 2-Octyl-3-isothiazolinone has a good control effect on tobacco brown spot disease. The control effects of 100 μg / mL and 200 μg / mL 2-octyl-3-isothiazolinone are 80.80% and 84.33%, respectively, which are higher than the control effect of 40% sclerotium net, but the difference is not significant.
[0049] Table 3 Field test of 2-octyl-3-isothiazolinone in controlling tobacco brown spot disease
[0050] deal with Disease index Relative efficacy (%) CK (0.5% DMSO) 25.84a 100μg / mL 2-octyl-3-isothiazolinone 4.96b 80.80a 200 μg / mL 2-octyl-3-isothiazolinone 4.05c 84.33a 40% Sclerotium net 400 times liquid 5.13c 80.15a
[0051] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the purpose and scope of the technical solution, which should be included in the scope of the claims of the present invention.
Claims
1. Application of 2-octyl-3-isothiazolinone as an antibacterial substance.
2. Application of 2-octyl-3-isothiazolinone as a pesticide for preventing and treating tobacco black shank.
3. Application of 2-octyl-3-isothiazolinone as a pesticide for preventing and controlling tobacco brown spot disease.
4. The molecular formula of 2-octyl-3-isothiazolinone according to any one of claims 1 to 3 is C 11 H 19 NOS, the structural formula is shown in I:
5. 2-Octyl-3-isothiazolinone according to claim 3, characterized in that: The 2-octyl-3-isothiazolinone is identified from the metabolites of co-culture of Bacillus subtilis and Trichoderma aculeatus.
6. 2-Octyl-3-isothiazolinone according to claim 4, characterized in that The steps for identifying metabolites from the co-culture of Bacillus subtilis and Trichoderma aspergillus are: (1) Trichoderma aspergillus HG1 was cultured in PDA medium at 28°C for 5 days, the spores were washed with sterile water, 20 μL of the spore suspension was dropped into a cell counting plate and the number of spores was counted using an automatic cell counter, and the concentration of the spore suspension was adjusted to 1×105 CFU / mL with sterile water to obtain a Trichoderma aspergillus HG1 spore suspension; Bacillus subtilis Tpb55 was cultured in NA medium for 24 h, inoculated in LB medium, and cultured at 28°C and 180 rpm for 24 h. 200 μL of bacterial solution was placed in a microplate and the OD600 value was read by a microplate reader. The bacterial solution was diluted to a concentration of 1×106 CFU / mL with sterile water to obtain a Tpb55 bacterial suspension. (2) 5 mL of Trichoderma aspergillus HG1 spore suspension was inoculated into 250 mL of LB medium alone, and fermented at 28°C and 180 rpm for 7 days to obtain a single culture fermentation liquid H; 500 μL of Bacillus subtilis Tpb55 bacterial suspension was inoculated into 250 mL of LB medium alone, and fermented at 28°C and 180 rpm for 6 days to obtain a single culture fermentation liquid T; 5 mL of Trichoderma aspergillus HG1 and 500 μL of Bacillus subtilis Tpb55 were sequentially inoculated into LB broth with an inoculation time interval of 24 hours, and co-cultured at 28°C and 180 rpm for 7 days to obtain a co-culture fermentation liquid HT; (3) 50 mL of each H, T and HT fermentation broth was centrifuged at 6000 rpm for 5 min, washed with PBS buffer, and centrifuged three times to remove the culture medium to obtain mycelial extracts, which were quickly frozen in liquid nitrogen and stored at -80°C; 100 mg of each sample was placed in a 1.5 mL microcentrifuge tube, 500 μL of 80% methanol aqueous solution was added, vortexed and ice-bathed for 5 min, centrifuged at 4°C and 15000 rpm for 20 min, and the supernatant was collected for LC-MS analysis; the LC-MS / MS used the following elution system in positive and negative ion modes: in positive ion mode, the mobile phase was 0.1% formic acid and the mobile phase was methanol; in negative ion mode, the mobile phase was 5 mM ammonium acetate, pH 9.0 and methanol as mobile phase; the column temperature was set at 40°C, the flow rate was 0.2 mL / min; the elution gradient was set as follows: 0 min, 12% B; 1.5 min, 2% B; 12 min, 100% B; 14 min, 100% B; 14.1 min, 2% B; 17 min, 2% B; (4) The raw data were screened by Compound Discoverer 3.1 for parameters such as retention time and charge-to-mass ratio, and then each metabolite was pre-aligned, peak extracted, and peak area quantified. The obtained information was then compared with three databases: mzCloud, mzVault, and Masslist, and finally the results of metabolite identification and relative quantification were obtained. Statistical analysis was performed using statistical software R version R-3.4.3, Python 2.7.6 version, and CentOS release 6.
6. Partial least squares discriminant analysis (PLS-DA) was performed using metabolomics data processing software metaX. The statistical significance p-value and differential fold change of metabolites between groups were calculated based on univariate analysis T test. The screening criteria for differential metabolites were VIP>1.0, FC>1.5 or FC<0.667, and p-value<0.
05. Metabolomic analysis showed that co-culture of Trichoderma aspergillus HG1 and Bacillus subtilis Tpb55 could promote the production of secondary metabolites with antibacterial activity, including 2-octyl-3-isothiazolinone.
